×
About 34,353 results

ALLMedicine™ Bipolar Disorder Center

Research & Reviews  10,674 results

Trauma exposure and co-occurring ICD-11 post-traumatic stress disorder and complex post...
https://doi.org/10.1111/acps.13467
Acta Psychiatrica Scandinavica; Lewis C, Lewis K et. al.

Jun 27th, 2022 - To establish factors associated with ICD-11 post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD) in a large sample of adults with lived experience of psychiatric disorder and examine the psychiatric burden associated with the two disorde...

Aging in bipolar disorder: Cognitive performance and clinical factors based on an adult...
https://doi.org/10.1016/j.jad.2022.06.030
Journal of Affective Disorders; Montejo L, Solé B et. al.

Jun 26th, 2022 - The evolution of cognitive performance throughout the lifespan in bipolar disorder (BD) is understudied. This cross-sectional study aims to describe the cognitive performance across age groups. A sample of 654 participants was recruited for this s...

Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen
https://clinicaltrials.gov/ct2/show/NCT04684615

Jun 24th, 2022 - This protocol leverages existing NIMH studies and participants to accomplish time-sensitive research on the mental health impact of environmental stressors imposed by the COVID-19 pandemic. The study will describe the relationship between stressor...

Long-term Observation of Participants With Mood Disorders
https://clinicaltrials.gov/ct2/show/NCT04877977

Jun 24th, 2022 - Synopsis Title: Long-term Observation of Participants with Mood Disorders Study Description: The proposal will leverage existing data on former participants with mood disorders collected in the Experimental Therapeutics and Pathophysiology Branch ...

Antidepressant Effects of TS-161 in Treatment-Resistant Depression
https://clinicaltrials.gov/ct2/show/NCT04821271

Jun 24th, 2022 - OBJECTIVE Modulation of glutamatergic signaling is implicated in improvement of depressive symptoms and related constructs/dimensions of observable behavior and neurobiological measures with treatment. Current standard monoaminergic pharmacologica...

see more →

Guidelines  9 results

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for...
https://doi.org/10.1111/bdi.13135
Bipolar Disorders; Yatham LN, Chakrabarty T et. al.

Oct 3rd, 2021 - The 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided clinicians with pragmatic treatment recommendations for bipolar disorder (BD). While these guidelines inc...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947163
Bipolar Disorders; Yatham LN, Kennedy SH et. al.

Mar 15th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were p...

Methodological recommendations for cognition trials in bipolar disorder by the Internat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282834
Bipolar Disorders; Miskowiak KW, Burdick KE et. al.

Sep 13th, 2017 - To aid the development of treatment for cognitive impairment in bipolar disorder, the International Society for Bipolar Disorders (ISBD) convened a task force to create a consensus-based guidance paper for the methodology and design of cognition t...

see more →

Drugs  589 results see all →

Clinicaltrials.gov  1,001 results

Long-term Observation of Participants With Mood Disorders
https://clinicaltrials.gov/ct2/show/NCT04877977

Jun 24th, 2022 - Synopsis Title: Long-term Observation of Participants with Mood Disorders Study Description: The proposal will leverage existing data on former participants with mood disorders collected in the Experimental Therapeutics and Pathophysiology Branch ...

Antidepressant Effects of TS-161 in Treatment-Resistant Depression
https://clinicaltrials.gov/ct2/show/NCT04821271

Jun 24th, 2022 - OBJECTIVE Modulation of glutamatergic signaling is implicated in improvement of depressive symptoms and related constructs/dimensions of observable behavior and neurobiological measures with treatment. Current standard monoaminergic pharmacologica...

Evaluation of the Genetics of Bipolar Disorder
https://clinicaltrials.gov/ct2/show/NCT00001174

Jun 24th, 2022 - Bipolar affective disorder is a severe, heritable condition affecting about one percent of the population. The mode of inheritance is poorly understood and probably involves multiple loci of small to moderate effect. In this project, we use geneti...

Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
https://clinicaltrials.gov/ct2/show/NCT00006177

Jun 24th, 2022 - Objective: For this protocol we define Bipolar Spectrum disorders (BSD) as the propensity to have a manic episode by having Bipolar Disorder or Substance/Medication-Induced Bipolar and Related Disorder. BSD in children and adolescents is receiving...

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
https://clinicaltrials.gov/ct2/show/NCT00025935

Jun 24th, 2022 - Objective: Irritability is a common and impairing clinical presentation in youth. Despite its significant public health impact, the clinical course and pathophysiology of irritability remains poorly understood. Chronic and severe irritability is t...

see more →

News  1,446 results

Defusing Patient-Physician Conflict the LATTE Way
https://www.medscape.com/viewarticle/976046

Jun 24th, 2022 - Alexa Mieses Malchuk, MD, MPH Mr L was a young man coming to see me for the first time. The reason for the visit was to establish care with a new primary care clinician, but he was also experiencing insomnia. In the past, Mr L has been afflicted w...

Fast Five Quiz: Bipolar Disorder With Agitation
https://www.medscape.com/viewarticle/960511

Jun 17th, 2022 - Bipolar I disorder is a chronic mood disorder characterized by at least one manic episode lasting a minimum of 7 days. Most individuals also experience depressive episodes, typically lasting at least 2 weeks. Agitation, or severe restlessness, is ...

Youth With Bipolar Disorder at High Risk of Eating Disorders
https://www.medscape.com/viewarticle/975126

Jun 6th, 2022 - Youth with bipolar disorder (BD) have a high risk of eating disorders (EDs), new research shows. Investigators studied close to 200 youth with BD and found that more than 25% had a lifetime ED, which included anorexia nervosa (AN), bulimia nervosa...

Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2)
https://www.mdedge.com/psychiatry/article/254984/neurotransmitter-based-diagnosis-and-treatment-hypothesis-part-2
Dmitry M. Arbuck, MD, José Miguel Salmerón, MD et. al.

Jun 1st, 2022 - There is a need to connect mental and physical symptoms in the diagnosis and treatment of psychiatric disorders. Obviously, we are not yet equipped to clearly recognize which neurotransmitters cause which symptoms.

see more →

Patient Education  22 results see all →